Cowa, LLC Gilead Sciences, Inc. Transaction History

Cowa, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$59.54 - $68.01 $129,261 - $147,649	2,171 New	2,171 $134,000
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $12.8 Million - $16.1 Million	221,486 New	221,486 $132,000
Q2 2021 Aug 02, 2021	SELL	$63.47 - $69.35 $123,956 - $135,440	-1,953 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$60.0 - $68.46 $72,120 - $82,288	1,202 Added 160.05%	1,953 $129,000
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $42,544 - $48,477	751 New	751 $45,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Cowa, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowa, LLC with notifications on news.